BIOPHYTIS fait le point sur ses programmes d’accès précoce pour Sarconeos (BIO101) dans le traitement des formes sévères de COVID-19
BIOMUNEX a French company specialized in immunotherapy, presents the latest preclinical results on its disruptive MAIT cell redirection approach for cancer treatment at the 2023 AACR1 Annual Meeting
ALGOTHERAPEUTIX Announces First Patients Dosed in US and European Arms of Phase II Clinical Trial of ATX01 in Rare Disease Erythromelalgia
AGS THERAPEUTICS Named among Business Worldwide Magazines 20 Most Innovative Companies to Watch in 2023